gee I was talking about actual patients. You know, actual people, that have diseases, like cancer, and maybe kevetrin can help with their quality of life, or their survival.
Not preclinical- I mean we are past that, now, right? OK maybe I get it- if you want to see kevetrin efficacy that is the ONLY place you can look. Sure, remain in the preclinical world, OK
And what p53 modulation? Pretty dandy. it is comforting to know that on a molecular level, the drug is doing something. And here I thought we already knew that from preclinical, right?
Some here have just written(total malarkey)that p53 modulation is where it's at.
When there has to be just a little bit more- making sick people get better. Is that hard to grasp?
Why would anyone pretend otherwise? Because they are just kidding around? I suppose that must be it. Or it's early dementia? Or hallucinogens?
We are not amused
Market Data 
Markets 
AI
